MabDesign Network provides scientific, technological, and business expertise in biotherapies and bioproduction, for the benefit of drug developers as well as service providers. Founded in 2014, self-financed and strong of over 370 French and European members, the MabDesign association is committed to being the leading expert resource for stakeholders in this highly innovative field. With this aim, our science-oriented team proposes conferences, trainings courses and publications to disseminate innovations, along with business services to support the marketing, business development and non-dilutive financing of your innovations.

Visit our website www.mabdesign.fr/en/ to learn more about our activities!

You can also follow us on LinkedIn.